Vernalis (VER)

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

32.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 38.00
  • 52 Week Low: 22.50
  • Currency: UK Pounds
  • Shares Issued: 442.27m
  • Volume: 50,000
  • Market Cap: 142.63m
  • RiskGrade: 107
  • Beta: 0.25

Deal with Barclays Trade now with Barclays Stockbrokers

Vernalis Overview

Vernalis is in the pharmaceuticals & biotechnology sector and is currently trading at 32.25p per share. In the last year Vernalis's share price has ranged from 22.50p to 38.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -40.4% -107.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 10.1 13.7
Pr/Book 1.7  
Latest F'cast
Revenue -3.6% -26.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Vernalis Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-09 13.02 (14.34) (25.90)p n/a n/a n/a n/a 0.0%
31-Dec-10 14.20 (22.13) (3.00)p n/a n/a n/a n/a 0.0%
31-Dec-11 12.16 (10.61) (6.50)p n/a n/a n/a n/a 0.0%
31-Dec-12 14.62 (6.84) (1.40)p n/a n/a n/a n/a 0.0%
31-Dec-13 14.08 (6.27) (1.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Vernalis Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 10.39 (11.12) (2.01)p n/a n/a n/a n/a 0.0%
31-Dec-15 13.51 (16.46) (3.05)p n/a n/a n/a n/a 0.0%

Copyright © 2014 FactSet Research Systems Inc. All rights reserved.

Vernalis Company Announcements

Total Voting Rights 31-Jul-2014 07:00 RNS
3rd Product in Cough Cold Pipeline Achieves POC 22-Jul-2014 07:00 RNS
Notice of Results for 6 Months Ended 30 June 2014 17-Jul-2014 07:00 RNS

Latest Vernalis Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Vernalis Market Data

Currency UK Pounds
Share Price 32.25p
Change Today -0.50p
% Change -1.53 %
52 Week High 38.00
52 Week Low 22.50
Volume 50,000
Shares Issued 442.27m
Market Cap 142.63m
Beta 0.25
RiskGrade 107

Vernalis Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.94% below the market average14.94% below the market average14.94% below the market average14.94% below the market average14.94% below the market average
52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average52.38% above the sector average
Price Trend
46.48% above the market average46.48% above the market average46.48% above the market average46.48% above the market average46.48% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income Not Available
Growth
18.44% below the market average18.44% below the market average18.44% below the market average18.44% below the market average18.44% below the market average
Sector averageSector averageSector averageSector averageSector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Vernalis Dividends

No dividends found

Trades for 01-Aug-2014

Time Volume / Share Price
11:41 50,000 @ 31.75p

Vernalis Key Personnel

CFO David Mackney
CEO Ian Garland

Top of Page